tradmap

NEOG Financials Neogen Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 13.2% per year over the past 5 years.
  • Operating margin has contracted, at -2.5% in the latest year.
  • Free cash flow has declined 10.1% per year over the past 5 years.

Financial health

  • Total debt ($794M) exceeds cash ($186M); net debt is $608M.
  • Operating income covered interest expense -0.9× in the latest year.
  • Total debt is 8.4× EBITDA.
Revenue & net income
-$1B -$84M $924M $0 2012 2014 2016 2018 2020 2022 2024 2026
RevenueNet income
Margins (gross / operating / net)
-122% -36% 50% 0% 2012 2014 2016 2018 2020 2022 2024 2026
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-53% -21% 11% 0% 2012 2014 2016 2018 2020 2022 2024 2026
ROEROA
Free cash flow (CFO − capex)
-$76M -$7M $62M $0 2012 2014 2016 2018 2020 2022 2024 2026
Free cash flow
Cash vs total debt
$0 $447M $894M 2012 2014 2016 2018 2020 2022 2024 2026
CashTotal debt
Cash flow: operating / investing / financing
-$119M $41M $201M $0 2012 2014 2016 2018 2020 2022 2024 2026
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2026 $870M -$8M 46.9% -2.5% -0.4% -0.2% $32M $794M $186M
2025 $895M -$1.1B 47.1% -118.6% -52.7% -31.7% -$46M $894M $129M
2024 $924M -$9M 50.2% 6.3% -0.3% -0.2% -$76M $891M $171M
2023 $822M -$23M 49.4% 4.6% -0.7% -0.5% -$25M $885M $163M
2022 $527M $48M 46.1% 11.1% 5.4% 4.9% $44M $0 $44M
2021 $468M $61M 45.9% 15.8% 7.2% 6.6% $54M $76M
2020 $418M $59M 46.9% 16.1% 8.2% 7.5% $62M $66M
2019 $414M $60M 46.3% 16.4% 9.4% 8.6% $49M $42M
2018 $398M $63M 46.8% 17.6% 11.3% 10.2% $48M $83M
2017 $358M $44M 47.1% 18.1% 9.3% 8.3% $46M $78M
2016 $321M $37M 47.6% 17.6% 9.0% 8.1% $21M $55M
2015 $34M 9.6% 8.5% $66M
2014 $28M 9.2% 8.2% $10M $41M
2013 $27M 10.5% 9.4% $18M $50M
2012 $23M 10.3% 8.9% $10M $49M

Valuation over time

How the market has priced NEOG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 41.8 83.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 3.8 7.7 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is NEOG growing its revenue and profit?

Over the past 5 years, Neogen Corp's revenue has grown 13.2% per year. These are computed facts, not advice.

How much debt does NEOG have?

As of FY2026, Neogen Corp reported $794M of total debt against $186M of cash; operating income covered interest expense -0.9×.

What is NEOG's profit margin?

In FY2026, gross margin was 46.9%, operating margin -2.5%, and net margin -0.9%.

What is NEOG's P/E ratio?

As of Sep '26, Neogen Corp traded at a price-to-earnings ratio of about 77.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.